Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
50 participants
OBSERVATIONAL
2023-10-15
2024-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Follow-Up of Patients Treated With Hypofractionated Stereotactic Photon Radiotherapy Due to Uveal Melanoma
NCT06280040
Definity for Ultrasound of Intraocular Tumors
NCT01930968
Non-invasive Optical Angiography in Age-related Macular Degeneration
NCT02521142
Prevalence of Vitreomacular Adhesion in Patients 40 Years and Older
NCT02160340
Imaging of the Angiofibrotic Switch in Neovascular AMD
NCT03838679
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Uveal Melanoma
Patients with uveal melanoma will undergo a routine diagnostic imaging with color fundus photography and sonography.
Sonography, color fundus photography
Patients will undergo routine diagnostic imaging (Sonography, color fundus photography)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sonography, color fundus photography
Patients will undergo routine diagnostic imaging (Sonography, color fundus photography)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Imaging not feasible due to any reason.
18 Years
99 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University of Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Reinhard Told
MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Reinhard Told, MD, PhD, Priv.-Doz.
Role: PRINCIPAL_INVESTIGATOR
Deparment of Ophthalmology and Optometry
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medical University of Vienna, Department of Ophthalmology and Optometry
Vienna, , Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Uveal Melanoma 1942/2022
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.